Leukocytic promotion of prostate cellular proliferation
- 28 October 2009
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 70 (4), 377-389
- https://doi.org/10.1002/pros.21071
Abstract
BACKGROUND Histological evidence of pervasive inflammatory infiltrate has been noted in both benign prostatic hyperplasia/hypertrophy (BPH) and prostate cancer (PCa). Cytokines known to attract particular leukocyte subsets are secreted from prostatic stroma consequent to aging and also from malignant prostate epithelium. Therefore, we hypothesized that leukocytes associated with either acute or chronic inflammation attracted to the prostate consequent to aging or tumorigenesis may promote the abnormal cellular proliferation associated with BPH and PCa. METHODS An in vitro system designed to mimic the human prostatic microenvironment incorporating prostatic stroma (primary and immortalized prostate stromal fibroblasts), epithelium (N15C6, BPH‐1, LNCaP, and PC3 cells), and inflammatory infiltrate (HL‐60 cells, HH, and Molt‐3 T‐lymphocytes) was developed. Modified Boyden chamber assays were used to test the ability of prostate stromal and epithelial cells to attract leukocytes and to test the effect of leukocytes on prostate cellular proliferation. Antibody arrays were used to identify leukocyte‐secreted cytokines mediating prostate cellular proliferation. RESULTS Leukocytic cells migrated towards both prostate stromal and epithelial cells. CD4+ T‐lymphocytes promoted the proliferation of both transformed and non‐transformed prostate epithelial cell lines tested, whereas CD8+ T‐lymphocytes as well as dHL‐60M macrophagic and dHL‐60N neutrophilic cells selectively promoted the proliferation of PCa cells. CONCLUSIONS The results of these studies show that inflammatory cells can be attracted to the prostate tissue microenvironment and can selectively promote the proliferation of non‐transformed or transformed prostate epithelial cells, and are consistent with differential role(s) for inflammatory infiltrate in the etiologies of benign and malignant proliferative disease in the prostate. Prostate 70: 377–389, 2010.Keywords
Funding Information
- NIDDK/NIH George M. O'Brien Center for Urologic Research (1 P50 DK065313)
- NIH/NIDDK (1 R01 DK081841, 2T32DK007758)
This publication has 50 references indexed in Scilit:
- CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesisJournal of Cellular Physiology, 2009
- Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancerProceedings of the National Academy of Sciences, 2009
- The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophyCytokine, 2008
- Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activationCarcinogenesis: Integrative Cancer Research, 2008
- Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammationThe Prostate, 2008
- Inflammatory cell infiltration of tumors: Jekyll or HydeCancer and Metastasis Reviews, 2007
- The DEK Nuclear Autoantigen Is a Secreted Chemotactic FactorMolecular and Cellular Biology, 2006
- Human T lymphocytes and mast cells differentially express and regulate extra‐ and intracellular CXCR1 and CXCR2Experimental Dermatology, 2004
- Immunological Memory and Protective Immunity: Understanding Their RelationScience, 1996
- Establishment of an IL‐2 independent, human T‐cell line possessing only the p70 IL‐2 receptorInternational Journal of Cancer, 1991